GOLDSMITH MARK A sold RVMD
September 16, 2026 · Form 4 insider transaction
GOLDSMITH MARK A sold 13,775 shares of Revolution Medicines, Inc. at $199.30 per share, a transaction worth $2.75M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
13,775
Price
$199.30
Total value
$2.75M
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 16, 2026
Filing dateSeptember 18, 2026
Shares owned after253,342
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units.; Includes 157,588 restricted stock units.